Healome Therapeutics is a clinical stage company developing treatments for eye conditions, with a particular interest in ocular surface diseases and injuries.​

 

We aim to create products that can help patients and healthcare care providers to obtain transformative clinical and quality of life outcomes through the safest, simplest, and most scalable approaches possible. 

 

Our current products under development are based on a proprietary eye drop technology offering combined drug retention, lubrication and protection at the ocular surface.​

 

While we strive to transform eye care over the longer-term, we are committed to improving the field in the near-term as well. Using our technology, we aim to enhance the therapeutic value of existing ocular medicines through reformulation, and develop novel therapeutics that could transform the management of ocular surface health.